immune system
• mice have lower secretion of keratinocyte chemokine (CXCL1) in the airway after 1 ng dose of LPS
• mice have higher secretion of CXCL1 in the airway after 100 ng dose of LPS compared to LPS-treated controls
|
• there is less secretion of TNF in the airway after 1 ng dose of LPS compared to LPS-treated controls
|
• mice are resistant to airway sensitivity induced by low intranasal doses of LPS but have augmented inflammatory responses to high doses of LPS
• mice have lower neutrophil influx and secretion of TNF and keratinocyte chemokine in the airway after 1ng dose of LPS
• mice have enhanced neutrophil influx and cytokine secretion after a 100ng LPS dose compared to controls
• histological scoring confirms more severe inflammation in the lungs 6 and 22 hours after 100 ng LPS administration
|
• mice are resistant to airway sensitivity induced by low intranasal doses of LPS but have augmented inflammatory responses to high doses of LPS
|
• mice have lower neutrophil influx into the airways with 1ng dose of LPS but higher neutrophil influx with 100ng doses of LPS
|
homeostasis/metabolism
• mice have lower secretion of keratinocyte chemokine (CXCL1) in the airway after 1 ng dose of LPS
• mice have higher secretion of CXCL1 in the airway after 100 ng dose of LPS compared to LPS-treated controls
|
hematopoietic system
• mice have lower neutrophil influx into the airways with 1ng dose of LPS but higher neutrophil influx with 100ng doses of LPS
|